Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats
暂无分享,去创建一个
Masaru Sugimachi | Kenji Sunagawa | Toru Kawada | Can Zheng | Meihua Li | M. Sugimachi | K. Sunagawa | T. Kawada | C. Zheng | Meihua Li | Takayuki Sato | Takayuki Sato
[1] M. A. Plant. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality , 1991 .
[2] M. Sugimachi,et al. The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure. , 1998, Journal of cardiac failure.
[3] J. Cohn,et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.
[4] Jerome V. Murphy,et al. Stimulation of the Nervous System for the Management of Seizures , 2003, CNS drugs.
[5] S. Reid. Surgical Technique for Implantation of the Neurocybernetic Prosthesis , 1990, Epilepsia.
[6] P. Douglas,et al. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. , 1994, Circulation.
[7] P. Schwartz,et al. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. , 1992, Circulation.
[8] P. Saxena,et al. Low-dose aspirin improves in vivo hemodynamics in conscious, chronically infarcted rats. , 1998, Cardiovascular research.
[9] M. Pfeffer. Left ventricular remodeling after acute myocardial infarction. , 1995, Annual review of medicine.
[10] G. Zhao,et al. Selective impairment of vagally mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure. , 1995, Circulation.
[11] D. Mann. Tumor necrosis factor-induced signal transduction and left ventricular remodeling. , 2002, Journal of cardiac failure.
[12] Masaru Sugimachi,et al. Bionic Technology Revitalizes Native Baroreflex Function in Rats With Baroreflex Failure , 2002, Circulation.
[13] M. Pfeffer,et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. , 1985, Circulation.
[14] Effect of carvedilol on survival in severe chronic heart failure. , 2001 .
[15] S. Dhein,et al. Muscarinic receptors in the failing human heart. , 1999, European journal of pharmacology.
[16] J. Smits,et al. Time-related adaptations in plasma neurohormone levels and hemodynamics after myocardial infarction in the rat. , 1998, Journal of cardiac failure.
[17] P. Douglas,et al. Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure , 1999, British journal of pharmacology.
[18] P. Schwartz,et al. Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. , 1991, Circulation research.
[19] M. Sugimachi,et al. Increased brain angiotensin receptor in rats with chronic high-output heart failure. , 2000, Journal of cardiac failure.
[20] A. Mallet,et al. Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001, Circulation.
[21] G Cooper,et al. Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. , 2000, Circulation.
[22] A. Zamotrinsky,et al. Vagal neurostimulation in patients with coronary artery disease , 2001, Autonomic Neuroscience.
[23] L. Minutoli,et al. Efferent Vagal Fibre Stimulation Blunts Nuclear Factor-&kgr;B Activation and Protects Against Hypovolemic Hemorrhagic Shock , 2003, Circulation.
[24] K Sagawa,et al. Ventricular efficiency predicted by an analytical model. , 1986, The American journal of physiology.
[25] A. Mark. Sensitization of cardiac vagal afferent reflexes at the sensory receptor level: an overview. , 1987, Federation proceedings.
[26] S. Goldman,et al. Ventricular remodeling in heart failure. , 2002, Journal of cardiac failure.
[27] Markel' Al. Sensitization of cardiac vagal afferent reflexes at the sensory receptor level: an overview. , 1987 .
[28] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[29] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[30] S. S. Hull,et al. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. , 1991, Circulation research.
[31] J. Bigger,et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.
[32] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[33] K. Swedberg,et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.
[34] N. Hollenberg,et al. Literature alert , 2002 .
[35] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[36] J. Sanderson,et al. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. , 2000, Journal of the American College of Cardiology.